J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 88 (2007), 2435-2440; DOI 10.1099/vir.0.82925-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary figures
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gealy, C.
Right arrow Articles by Caswell, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gealy, C.
Right arrow Articles by Caswell, R.
Agricola
Right arrow Articles by Gealy, C.
Right arrow Articles by Caswell, R.

Short Communication

An activation-defective mutant of the human cytomegalovirus IE2p86 protein inhibits NF-{kappa}B-mediated stimulation of the human interleukin-6 promoter

Claire Gealy1, Christine Humphreys1, Vicky Dickinson1,{dagger}, Mark Stinski2 and Richard Caswell1

1 Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3US, UK
2 Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA

Correspondence
Richard Caswell
CaswellR{at}cf.ac.uk

The IE2p86 protein of human cytomegalovirus is an essential activator of early- and late-phase viral gene expression. Whilst IE2p86 activates expression of a number of cellular genes, it also represses certain cellular genes, particularly those activated by nuclear factor {kappa}B (NF-{kappa}B). As the interleukin-6 (IL-6) promoter can be activated by both NF-{kappa}B and IE2p86, it was examined whether there is competition between these two factors. Here, it is reported that both wild-type and mutant IE2p86 can block activation of the IL-6 promoter in response to interleukin-1beta. By using an artificial activator in which the activation domain of NF-{kappa}B is directed to the promoter by the GAL4 DNA-binding domain, it is shown that the mutant form of IE2p86 can inhibit NF-{kappa}B-mediated activation at a step subsequent to promoter recruitment. These data therefore suggest a novel mechanism for inhibition of NF-{kappa}B by IE2p86.

{dagger}Deceased.

Supplementary figures showing binding of IE2p86 and CAD291 to basal transcription factors in vitro and the sequence of the human IL-6 promoter are available with the online version of this paper.




This article has been cited by other articles:


Home page
J. Virol.Home page
P. Lashmit, S. Wang, H. Li, H. Isomura, and M. F. Stinski
The CREB Site in the Proximal Enhancer Is Critical for Cooperative Interaction with the Other Transcription Factor Binding Sites To Enhance Transcription of the Major Intermediate-Early Genes in Human Cytomegalovirus-Infected Cells
J. Virol., September 1, 2009; 83(17): 8893 - 8904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 by the Society for General Microbiology.